EUVIMEDEUVIMED entdecken
Netzwerk-Metaanalyse

L26/P-482 Placebo effect on reproductive outcomes in recurrent implantation failure: a network meta-analysis of randomized controlled trials

A. Almohammadi, F. Choucair, K. Khan, A. Elsayid, N. Cano-Ibáñez

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.815 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Almohammadi und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Is there evidence of a placebo-associated effect on reproductive outcomes in randomized controlled trials (RCTs) of recurrent implantation failure (RIF)? Summary answer Placebo-associated responses were observed for clinical pregnancy but not live birth, suggesting that non-specific effects may influence intermediate outcomes in RIF trials. What is known already RIF remains a major challenge in assisted reproduction, with limited high-quality evidence supporting most adjuvant therapies. In RCTs, observed improvements may partly reflect non-specific responses related to trial participation or comparator choice rather than true treatment effects. While placebo and no-treatment controls are both used in RIF trials, their relative influence on estimated clinical pregnancy rates (CPR) and live birth rates (LBR) has not been systematically evaluated. Study design, size, duration This umbrella review and network meta-analysis was prospectively registered in PROSPERO (CRD42022332898). A systematic search was conducted in PubMed, Scopus, and the Cochrane Central Register of Controlled Trials databases from inception to December 2025. Twenty-five systematic reviews were included, comprising 47 RCTs contributing to the CPR network meta-analysis and 26 RCTs contributing to the LBR network in women with RIF. Participants/materials, setting, methods Systematic reviews including RCTs of women with RIF comparing active interventions with placebo and/or no treatment were eligible. Methodological quality of included reviews was assessed using AMSTAR-2, and the risk of bias of RCTs contributing to the network was evaluated using the Cochrane Risk of Bias 2 tool. A network meta-analysis compared CPR and LBR across placebo, no-treatment, and active intervention arms, with treatment rankings estimated using the surface under the cumulative ranking curve (SUCRA). Main results and the role of chance Twenty-five systematic reviews were included, comprising 47 RCTs reporting CPR and 26 RCTs reporting LBR. According to AMSTAR-2, review quality was rated as high in 8%, moderate in 12%, low in 48%, and critically low in 32% of the included systematic reviews. For CPR, placebo arms demonstrated higher outcomes compared with no treatment (OR = 1.48, 95% CI: 1.03–2.13; p = 0.032; SUCRA = 0.495), indicating a placebo-associated effect for this outcome. Active interventions showed larger effects than no treatment (OR = 2.22, 95% CI: 1.84–2.68; p < 0.001; SUCRA = 0.997). In analyses of individual interventions, placebo ranked higher than endometrial injury for CPR (SUCRA = 0.286 vs. 0.214). For LBR, placebo was not associated with a statistically significant difference compared with no treatment (OR = 1.16, 95% CI: 0.56–2.39; p = 0.691; SUCRA = 0.340), indicating no clear placebo-associated effect for live birth. Active interventions were associated with higher LBR compared with no treatment (OR = 2.09, 95% CI: 1.34–3.27; p = 0.001; SUCRA = 0.987). No significant inconsistency or small-study effects were detected. Limitations, reasons for caution Heterogeneity in study design, interventions, and definitions of RIF may limit generalizability. Several contributing trials were at risk of performance bias, particularly due to incomplete blinding, which may have influenced the observed placebo-associated and treatment responses. Wider implications of the findings These findings highlight a potentially hidden, non-specific placebo-associated response in assisted reproductive technologies trials, emphasizing the importance of comparator selection in trial design and cautious interpretation of reported treatment effects. Trial registration number Yes

Zitieren

APA

Almohammadi, A., Choucair, F., Khan, K., Elsayid, A., & Cano-Ibáñez, N. (2026). L26/P-482 Placebo effect on reproductive outcomes in recurrent implantation failure: a network meta-analysis of randomized controlled trials. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.815

Vancouver

Almohammadi A, Choucair F, Khan K, Elsayid A, Cano-Ibáñez N. L26/P-482 Placebo effect on reproductive outcomes in recurrent implantation failure: a network meta-analysis of randomized controlled trials. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.815

BibTeX
@article{Almohammadi2026,
  author = {Almohammadi, A. and Choucair, F. and Khan, K. and Elsayid, A. and Cano-Ibáñez, N.},
  title = {L26/P-482 Placebo effect on reproductive outcomes in recurrent implantation failure: a network meta-analysis of randomized controlled trials},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.815}
}
Kostenlos starten →